Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan.
Mol Ther
; 29(7): 2366-2377, 2021 07 07.
Article
in En
| MEDLINE
| ID: mdl-33781913
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccines, Synthetic
/
Leishmaniasis, Cutaneous
/
CD8-Positive T-Lymphocytes
/
Leishmaniasis Vaccines
/
Leishmania
/
Antigens, Protozoan
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
/
Male
Language:
En
Journal:
Mol Ther
Journal subject:
BIOLOGIA MOLECULAR
/
TERAPEUTICA
Year:
2021
Document type:
Article
Affiliation country:
Sudan